Early predisposition to osteomalacia in Indian adults on phenytoin or valproate monotherapy and effective prophylaxis by simultaneous supplementation with calcium and 25-hydroxy vitamin D at recommended daily allowance dosage: A prospective study

Neurology India

Volumn 58, Issue 2, 2010, Pages 213-219

  Krishnamoorthy, Geetha ^a   Nair, Rahul ^a   Sundar, Uma ^a   Kini, Prayag ^a   Shrivastava, Makardhwaj ^a  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

Author keywords

Anticonvulsant drug; bone metabolism; supplemental calcium and vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE BONE ISOENZYME; ALKALINE PHOSPHATASE ISOENZYME; ALKALINE PHOSPHATASE LIVER ISOENZYME; CALCIUM; CALCIUM LACTATE; CREATININE; MAGNESIUM; PHENYTOIN; PHOSPHORUS; UNCLASSIFIED DRUG; VALPROIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE PREDISPOSITION; DRUG EFFICACY; EPILEPSY; FEMALE; HUMAN; INDIA; MAGNESIUM BLOOD LEVEL; MALE; MONOTHERAPY; OSTEOMALACIA; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; SIDE EFFECT; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ADULT; ALKALINE PHOSPHATASE; ANTICONVULSANTS; BONE DENSITY CONSERVATION AGENTS; CALCIUM; CALCIUM, DIETARY; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMANS; INDIA; MALE; OSTEOMALACIA; PHENYTOIN; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TIME FACTORS; VALPROIC ACID; VITAMIN D; YOUNG ADULT;

EID: 77953730736     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.63796     Document Type: Article

References (26)

1. Christiansen C, Røodbro P, Sjö. Biochemical status in epileptic patients during treatment with vitamin D.A controlled therapeutic trial. Acta Neurol Scand 1975;52:81-86
2. Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology 2001;57:445-449
3. Petty SJ, Paton LM, O'Brien TJ, Makovey J, Erbas B, Sambrook P, et al. Effect of antiepileptic medication on bone mineral measures. Neurology 2005;65:1358-1363
4. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients Neurology 2002;58:1348-1353
5. Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal and postpubertal patients receiving carbamazepine. Epilepsia 2002;43:1488-1492
6. Kulak CA, Borba VZ, Bilezikian JP, Silvado CE, Paola L, Boguszewski CL. Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs. Arq Neuropsiquiatr 2004;62:940-948
7. Bianchini G, Mazzaferro S, Mancini U, Bianchi AR, Donato G, Massimetti C, et al. Calcium phosphorus changes in chronic anticonvulsant therapy: effects of administration of 25 hydroxy vitamin D3 on secondary hyperparathyroidism. Acta Vitaminol Enzymol 1983;5:229-234
8. Drezner MK. Treatment of anticonvulsant drug - induced bone disease. Epilepsy Behav 2004;5:S41-7.
9. Meyer-Sabellek W, Sinha P, Köttgen E. Alkaline phosphatase: Laboratory and clinical implications. J Chromatogr 1988;429:419-444
10. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000;11:76-82.
11. Harrison's Principles of Internal Medicine editors Kasper,Braunwald,Fauci Hauser, Longo, Jameson. 16th edition Volume I.
12. Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 1954;7: 322-326
13. Moss DW, Whitby LG. A simplified heat-inactivation method for investigating alkaline phosphatase isoenzymes in serum. Clin Chim Acta 1975;61:63-71.
14. Kessler G, Wolfman M. An automated procedure for the simultaneous determination of calcium and phosphorus. Clin Chem 1964;10: 686-703.
15. Aksnes L. A simplified high-performance liquid chromatographic method for determination of vitamin D3, 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human serum. Scand J Clin Lab Invest 1992;52:177-182
16. Lubran MM. The measurement of total serum proteins by the Biuret method. Ann Clin Lab Sci 1978;8:106-110
17. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with Bromocresol green. Clin Chim Acta 1971;31:87-96.
18. Aksnes L. A simplified high-performance liquid chromatographic method for determination of vitamin D3, 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human serum. Scand J Clin Lab Invest 1992;52:177-182
19. Gindler E. Estimation of magnesium. Clin Chem 1971;17:662.
20. Bonsne, Taussky. Determination of creatinine in urine. Varlwy's Practical clinical chemistry.5th edition.1980. p. 484.
21. Pødenphant J, Larsen NE, Christiansen C. An easy and reliable method for determination of urinary hydroxyproline. Clin Chim Acta 1984;142:145-148
22. Okesina AB, Donaldson D, Lascelles PT. Isoenzymes of alkaline phospatase in epileptic patients receiving carbamazepine monotherapy. J Clin Pathol 1991;44:480-482.
23. Khaira A, Gupta A, Madhu SV, Khaira DD. Phenytoin induced severe disabling osteomalacia in a young male with seizure disorder. J Assoc Physicians India 2008;56:376-378
24. Nijhawan R, Wierzbicki AS, Tozer R, Lascelles PT, Patsalos PN. Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes. Int J Clin Pharmacol Res 1990;10: 319-323
25. Howard JM. Anticonvulsant induced bone disease. Editorial. Arch Neurol.2004;58:1352-1353
26. Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice patterns of Neurologists regarding Bone and Mineral effects of antiepileptic drug therapy. Arch Neurol 2001;58:1369-1374